Company reports Quarterly reportsAnnual reports PresentationsAnnouncementsAnnual General MeetingFinancial calendarCorporate governanceData of sharesConferences, roadshowsAnalystsContact Latest reports Richter Group Report - 6 months to June 2020619 kb 08/03/2020let lt sRichter Group Report - 3 months to March 2020580 kb 05/08/2020let lt sGedeon Richter Consolidated Financial Statements 20192903 kb 04/09/2020let lt s Latest announcements Extraordinary Announcement10/26/20Extraordinary announcement10/05/20Richter and Mochida signed a license agreement 10/01/20Gedeon Richter Plc. (“Richter”) today announced that it has entered into a license agreement with Mochida Pharmaceutical Co. Ltd. (“Mochida”) in respect of Richter’s biosimilar tocilizumab (“Product”) for the treatment of rheumatoid arthritis.
Latest reports Richter Group Report - 6 months to June 2020619 kb 08/03/2020let lt sRichter Group Report - 3 months to March 2020580 kb 05/08/2020let lt sGedeon Richter Consolidated Financial Statements 20192903 kb 04/09/2020let lt s
Richter and Mochida signed a license agreement 10/01/20Gedeon Richter Plc. (“Richter”) today announced that it has entered into a license agreement with Mochida Pharmaceutical Co. Ltd. (“Mochida”) in respect of Richter’s biosimilar tocilizumab (“Product”) for the treatment of rheumatoid arthritis.
